AIHW logo
METEOR logo
Our sites
AIHW GEN Aged Care Data Aboriginal and Torres Strait Islander
Health Performance Framework
Indigenous Mental Health and
Suicide Prevention Clearinghouse
Australian Mesothelioma Registry Housing data Regional Insights for Indigenous Communities
Contact FAQs
  • Find metadata
    • Find metadata
    • Getting started
    • Data set specifications
    • Indicator sets
    • Data quality statements
    • Data dictionary archives
  • Metadata management
    • Metadata management
    • Data standards
    • Registration authorities
    • Registration statuses
  • How to use METEOR
    • How to use METEOR
    • First steps
    • Using My Page
    • Downloading and printing
    • FAQs
    • About METEOR
  • Learn about metadata
    • Learn about metadata
    • Metadata explained
    • How to create metadata
    • Metadata development resources

Person—diabetes therapy type, code NN

Identifying and definitional attributes

Metadata item type:Help on this termData Element
Short name:Help on this termDiabetes therapy type
METEOR identifier:Help on this term270236
Registration status:Help on this term
  • Health, Standard 01/03/2005
Definition:Help on this termThe type of diabetes therapy the person is currently receiving, as represented by a code.

Data element concept attributes

Identifying and definitional attributes

Data element concept:Person—diabetes therapy type
METEOR identifier:Help on this term269852
Registration status:Help on this term
  • Health, Standard 01/03/2005
Definition:Help on this termThe type of diabetes therapy the person is currently receiving.
Object class:Help on this termPerson
Property:Help on this termDiabetes therapy type

Value domain attributes

Identifying and definitional attributes

Value domain:Diabetes therapy code NN
METEOR identifier:Help on this term270787
Registration status:Help on this term
  • Health, Standard 01/03/2005
Definition:Help on this termA code set representing the type of diabetes mellitus therapy being used.

Representational attributes

Representation class:Help on this termCode
Data type:Help on this termString
Format:Help on this termNN
Maximum character length:Help on this term2
Permissible values:Help on this term
ValueMeaning
01Diet and exercise only
02Oral hypoglycaemic - sulphonylurea only
03Oral hypoglycaemic - biguanide (eg metformin) only
04Oral hypoglycaemic - alpha-glucosidase inhibitor only
05Oral hypoglycaemic - thiazolidinedione only
06Oral hypoglycaemic - meglitinide only
07Oral hypoglycaemic - combination (eg biguanide & sulphonylurea)
08Oral hypoglycaemic - other
09 Insulin only
10Insulin plus oral hypoglycaemic
98Nil - not currently receiving diabetes treatment
Supplementary values:Help on this term
ValueMeaning
99Not stated/inadequately described

Collection and usage attributes

Guide for use:Help on this term

CODE 01     Diet & exercise only

This code includes the options of generalised prescribed diet; avoid added sugar/simple carbohydrates (CHOs); low joule diet; portion exchange diet and uses glycaemic index and a recommendation for increased exercise.

CODE 98     Nil - not currently receiving diabetes treatment

This code is used when there is no current diet, tablets or insulin therapy(ies).

CODE 99     Not stated/inadequately described

Use this code when missing information.

Data element attributes

Collection and usage attributes

Collection methods:Help on this termTo be collected at the commencement of treatment and at each review.
Comments:Help on this term

In settings where the monitoring of a person's health is ongoing and where management can change over time (such as general practice), the Service contact—service contact date, DDMMYYYY should be recorded.

The main use of this data element is to enable categorisation of management regimes against best practice for diabetes.

Source and reference attributes

Submitting organisation:Help on this term

National Diabetes Data Working Group

Cardiovascular Data Working Group

Reference documents:Help on this termBerkow R, editor. The Merck Manual. 16th ed. Rahway (New Jersey, USA): Merck Research Laboratories; 1992.

Relational attributes

Related metadata references:Help on this term
Supersedes PDFDiabetes therapy type, version 1, DE, NHDD, NHIMG, Superseded 01/03/2005.pdf (19.1 KB) No registration status
See also Female—type of diabetes mellitus therapy during pregnancy, code N
  • Health, Standard 20/11/2019
See also Female—type of diabetes mellitus therapy during pregnancy, code N
  • Health, Superseded 20/11/2019
See also Female—type of diabetes mellitus therapy during pregnancy, code N
  • Health, Superseded 12/12/2018
See also Female—type of diabetes mellitus therapy during pregnancy, code N
  • Health, Superseded 02/08/2017
See also Female—type of diabetes mellitus therapy during pregnancy, code N
  • Health, Recorded 15/06/2022
Implementation in Data Set Specifications:Help on this term
All attributes +

Acute coronary syndrome (clinical) DSSHealth, Superseded 01/09/2012

Acute coronary syndrome (clinical) DSSHealth, Superseded 02/05/2013

Acute coronary syndrome (clinical) NBPDS Health, Recorded 15/05/2017

Acute coronary syndrome (clinical) NBPDS 2013-Health, Standard 02/05/2013

DSS specific attributes +

Implementation start date: 01/07/2013


Cardiovascular disease (clinical) DSSHealth, Superseded 15/02/2006

Cardiovascular disease (clinical) DSSHealth, Superseded 04/07/2007

Cardiovascular disease (clinical) DSSHealth, Superseded 22/12/2009

Cardiovascular disease (clinical) DSSHealth, Superseded 01/09/2012

Cardiovascular disease (clinical) NBPDSHealth, Superseded 17/10/2018

Cardiovascular disease (clinical) NBPDS Health, Standard 17/10/2018

Diabetes (clinical) DSSHealth, Superseded 21/09/2005

DSS specific attributes +

DSS specific information:

The objectives and priorities of treatment must be tailored to the individual considering age, sex, weight and individual health status.

An individual management plan for each patient should include the following:

  • establishment of targets of treatment
  • healthy eating plan
  • education in self-monitoring,
  • adjustment of treatment and in approaches to coping with emergencies
  • exercise program
  • risk factor reduction, e.g. smoking cessation
  • use of oral hypoglycaemic agents, if required
  • use of insulin, if required
  • screening for and treatment of complications of diabetes.

In addition to glycaemic control, management of diabetes of either type requires close attention to other risk factors for the development of complications, and the impact of lifestyle changes on blood glucose levels should be monitored. In patients with Type 2 diabetes, an increase in physical activity is essential in management of lipids and glucose level. Increased physical activity has been recognised as perhaps the most feasible way of modifying glucose intolerance, a risk factor for developing diabetes and macrovascular disease (Guest & O'Dea 1992).


Diabetes (clinical) NBPDSHealth, Standard 21/09/2005

DSS specific attributes +

DSS specific information:

The objectives and priorities of treatment must be tailored to the individual considering age, sex, weight and individual health status.

An individual management plan for each patient should include the following:

  • establishment of targets of treatment
  • healthy eating plan
  • education in self-monitoring,
  • adjustment of treatment and in approaches to coping with emergencies
  • exercise program
  • risk factor reduction, e.g. smoking cessation
  • use of oral hypoglycaemic agents, if required
  • use of insulin, if required
  • screening for and treatment of complications of diabetes.

In addition to glycaemic control, management of diabetes of either type requires close attention to other risk factors for the development of complications, and the impact of lifestyle changes on blood glucose levels should be monitored. In patients with Type 2 diabetes, an increase in physical activity is essential in management of lipids and glucose level. Increased physical activity has been recognised as perhaps the most feasible way of modifying glucose intolerance, a risk factor for developing diabetes and macrovascular disease (Guest & O'Dea 1992).


Diabetes (clinical) NBPDSHealth, Recorded 15/05/2017

DSS specific attributes +

DSS specific information:

The objectives and priorities of treatment must be tailored to the individual considering age, sex, weight and individual health status.

An individual management plan for each patient should include the following:

  • establishment of targets of treatment
  • healthy eating plan
  • education in self-monitoring,
  • adjustment of treatment and in approaches to coping with emergencies
  • exercise program
  • risk factor reduction, for example, smoking cessation
  • use of oral hypoglycaemic agents, if required
  • use of insulin, if required
  • screening for and treatment of complications of diabetes.

In addition to glycaemic control, management of diabetes of either type requires close attention to other risk factors for the development of complications, and the impact of lifestyle changes on blood glucose levels should be monitored. In patients with type 2 diabetes, an increase in physical activity is essential in management of lipids and glucose level. Increased physical activity has been recognised as perhaps the most feasible way of modifying glucose intolerance, a risk factor for developing diabetes and macrovascular disease (Guest & O'Dea 1992).

Reference:

 


Help
Downloading

The download may take a while, please wait.

Do not refresh the screen until the download is complete.

<Title>

<body>
<footer>
  • View
  • Show less
  • Print view
  • Download
  • Word™
  • Pdf
  • Advanced Download
  • Review
  • Compare items
© Australian Institute of Health and Welfare
Version 1.0.0+20220531.2